Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

[1]  Francesco Bettella,et al.  Shared common variants in prostate cancer and blood lipids. , 2014, International journal of epidemiology.

[2]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[3]  Simon G. Coetzee,et al.  Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci , 2014, PLoS genetics.

[4]  T. Weickert,et al.  What's Hot in Schizophrenia Research? , 2016, The Psychiatric clinics of North America.

[5]  V. Theodorou,et al.  GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility , 2013, Genome research.

[6]  Peter C Scacheri,et al.  Enhancer variants: evaluating functions in common disease , 2014, Genome Medicine.

[7]  K. Haugk,et al.  MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand , 2014, Oncotarget.

[8]  Eric Legius,et al.  PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies , 2014, Nature.

[9]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[10]  Paz Polak,et al.  Cell-of-origin chromatin organization shapes the mutational landscape of cancer , 2015, Nature.

[11]  Hunter B. Fraser,et al.  Pooled ChIP-Seq Links Variation in Transcription Factor Binding to Complex Disease Risk , 2016, Cell.

[12]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[13]  Henry W. Long,et al.  Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation , 2016, Nature Communications.

[14]  Clifford A. Meyer,et al.  Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics , 2012, Genome research.

[15]  Disorder Working Group.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 , 2012, Nature Genetics.

[16]  Clifford A. Meyer,et al.  Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.

[17]  Peter Kraft,et al.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array , 2013, Nature Genetics.

[18]  H. Klocker,et al.  SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer , 2013, Endocrine-related cancer.

[19]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[20]  S. Knapp,et al.  Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription , 2014, Cell reports.

[21]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[22]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[23]  L. Bubendorf,et al.  MED12 overexpression is a frequent event in castration-resistant prostate cancer. , 2014, Endocrine-related cancer.

[24]  C. Glass,et al.  The selection and function of cell type-specific enhancers , 2015, Nature Reviews Molecular Cell Biology.

[25]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[26]  Manuel A. R. Ferreira,et al.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 , 2011, Nature Genetics.

[27]  D. Taatjes,et al.  The human Mediator complex: a versatile, genome-wide regulator of transcription. , 2010, Trends in biochemical sciences.

[28]  J. Lindberg,et al.  Gene regulatory mechanisms underpinning prostate cancer susceptibility , 2016, Nature Genetics.

[29]  Aziz Khan,et al.  dbSUPER: a database of super-enhancers in mouse and human genome , 2015, bioRxiv.

[30]  O. Andreassen,et al.  All SNPs Are Not Created Equal: Genome-Wide Association Studies Reveal a Consistent Pattern of Enrichment among Functionally Annotated SNPs , 2013, PLoS genetics.

[31]  Nicole Soranzo,et al.  Functional interpretation of non-coding sequence variation: Concepts and challenges , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[33]  Kim Bure,et al.  Open Access Could Transform Drug Discovery: A Case Study of JQ1 , 2016, Expert opinion on drug discovery.

[34]  I. Mills,et al.  The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis , 2011, The EMBO journal.

[35]  C. Carlson,et al.  Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.

[36]  C. Glass,et al.  Reprogramming Transcription via Distinct Classes of Enhancers Functionally Defined by eRNA , 2011, Nature.

[37]  Y. Pu,et al.  Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  Simon G. Coetzee,et al.  Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. , 2015, Human molecular genetics.

[39]  Yang Zhao,et al.  Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls , 2012, Human molecular genetics.

[40]  Zhaohui S. Qin,et al.  Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer , 2014, Nature.